Medical cannabis company CS Medica has received sales approval in Azerbaijan and Georgia, which means that the company can complete distribution agreements with partner Hippokrat for a value of DKK 1,17 million.

The approvals concerned the company's Cannasen portfolio, according to a press release.

The company has also signed a new distribution agreement with Benotech in South Africa with an expected value of 2.5 million Danish customers.